New insights into snakebite epidemiology in Costa Rica: A retrospective evaluation of medical records

被引:19
作者
Sasa, Mahmood [1 ,2 ]
Cano, Sofia E. Segura [3 ]
机构
[1] Univ Costa Rica, Inst Clodomiro Picado, San Jose, Costa Rica
[2] Univ Costa Rica, Escuela Biol, Museo Zool, San Jose, Costa Rica
[3] Univ Costa Rica, Escuela Med, Dept Farmacol & Toxicol, San Jose, Costa Rica
关键词
Bothrops asper; Snake envenoming; Antivenom; Primary care facility; Epidemiology; ADVERSE-REACTIONS; CROTALIDAE POLYVALENT; HEALTH-CARE; BOTHROPS; ANTIVENOM; MORTALITY; BITES; SERUM; ENVENOMATION; IDENTIFICATION;
D O I
10.1016/j.toxcx.2020.100055
中图分类号
R99 [毒物学(毒理学)];
学科分类号
100405 ;
摘要
Continuous monitoring of the snakebite envenoming allows elucidating factors that affect its incidence at spatial and temporal scales, and is a great tool to evaluate the proper management of snakebite in health centers. To determine if there have been changes over time in snakebite epidemiology in Costa Rica, we conducted a retrospective study using medical records from six hospitals for the years 2012-2013. A total of 475 snakebite patients were treated at the selected hospital during this period. Most bites occurred during the rainy season and primarily affected young men, mainly farm workers and schoolchildren. About 55% of bites occur in peridomiciliary environments, although its prevalence varies geographically. Bothrops asper generates the vast majority of envenoming in the country, which is why the main local symptoms registered are edema, pain, and bleeding disorders. The time elapsed until treatment did not explain the degree of severity at admission. However, complications were observed more frequently in patients who took longer to receive treatment. The primary complications were bacterial infections, whereas kidney failure and compartment syndrome documented at very low frequencies. Only one death was recorded, reflecting the low fatality rate exhibited in the country. Hospital treatment included the rapid administration of antivenom and complementary treatment of antibiotics, analgesics, and antihistamines. The application of the latter as prophylactic does not seem to prevent the appearance of mild early adverse reactions, registered in 22.5% of the cases. Morbidity and mortality rates from snakebite have continued to decrease in the country, as a result of the efforts that Costa Rica has made to improve its public health system. Among those efforts, the creation of primary care centers (EBAIS) has reduced the time to treatment in many regions of the country. The Costa Rican experience of using antivenom in primary health care centers and maintaining good medical records could be considered for application in other countries where snakebite is a major health problem.
引用
收藏
页数:12
相关论文
共 99 条
[1]  
Abreu Mery Natali Silva, 2008, Cad. Saúde Pública, V24, ps581, DOI 10.1590/S0102-311X2008001600010
[2]   Randomised Controlled Double-Blind Non-Inferiority Trial of Two Antivenoms for Saw-Scaled or Carpet Viper (Echis ocellatus) Envenoming in Nigeria [J].
Abubakar, Isa S. ;
Abubakar, Saidu B. ;
Habib, Abdulrazaq G. ;
Nasidi, Abdulsalam ;
Durfa, Nandul ;
Yusuf, Peter O. ;
Larnyang, Solomon ;
Garnvwa, John ;
Sokomba, Elijah ;
Salako, Lateef ;
Theakston, R. David G. ;
Juszczak, Ed ;
Alder, Nicola ;
Warrell, David A. .
PLOS NEGLECTED TROPICAL DISEASES, 2010, 4 (07)
[3]  
Alfaro-Brianso B., 1983, Acta Med. Costarric., V26, P24
[4]   Dose of antivenom for the treatment of snakebite with neurotoxic envenoming: Evidence from a randomised controlled trial in Nepal [J].
Alirol, Emilie ;
Sharma, Sanjib Kumar ;
Ghimire, Anup ;
Poncet, Antoine ;
Combescure, Christophe ;
Thapa, Chabilal ;
Paudel, Vijaya Prasad ;
Adhikary, Kalidas ;
Taylor, Walter Robert ;
Warrell, David ;
Kuch, Ulrich ;
Chappuis, Francois .
PLOS NEGLECTED TROPICAL DISEASES, 2017, 11 (05)
[5]   Snake Bite in South Asia: A Review [J].
Alirol, Emilie ;
Sharma, Sanjib Kumar ;
Bawaskar, Himmatrao Saluba ;
Kuch, Ulrich ;
Chappuis, Francois .
PLOS NEGLECTED TROPICAL DISEASES, 2010, 4 (01)
[6]  
[Anonymous], 2010, Handbook of Venoms and Toxins of Reptiles
[7]  
Arroyo O., 1980, Bulletin of the Pan American Health Organization, V14, P280
[8]  
Arroyo O., 1999, ACTA MED COSTARRIC, V41, P23
[9]  
Avila-Aguero M. L., 2001, Journal of Venomous Animals and Toxins, V7, P69, DOI 10.1590/S0104-79302001000100006
[10]  
Bola~nos R., 1983, Rev. Costarric. Ciencias Med., V4, P27